» Articles » PMID: 20029462

Experimental Evidence on the Immunopathogenesis of Primary Biliary Cirrhosis

Overview
Date 2009 Dec 24
PMID 20029462
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease for which an autoimmune pathogenesis is supported by clinical and experimental data, including the presence of autoantibodies and autoreactive T cells. The etiology remains to be determined, yet data suggest that both a susceptible genetic background and unknown environmental factors determine disease onset. Multiple infectious and chemical candidates have been proposed to trigger the disease in a genetically susceptible host, mostly by molecular mimicry. Most recently, several murine models have been reported, including genetically determined models as well as models induced by immunization with xenobiotics and bacteria.

Citing Articles

A case report of primary biliary cholangitis combined with ankylosing spondylitis.

Hou C, Ren C, Luan L, Li S Medicine (Baltimore). 2023; 102(41):e35655.

PMID: 37832080 PMC: 10578735. DOI: 10.1097/MD.0000000000035655.


Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis.

Tian S, Hu Y, Zhang M, Wang K, Guo G, Li B Arthritis Res Ther. 2023; 25(1):186.

PMID: 37784152 PMC: 10544390. DOI: 10.1186/s13075-023-03163-y.


Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores.

Sohal A, Kowdley K Hepat Med. 2023; 15:63-77.

PMID: 37312929 PMC: 10259525. DOI: 10.2147/HMER.S361077.


The latest research trends in primary biliary cholangitis: a bibliometric analysis.

Zhao Y, Yin Z, Du H, Huang K, Zhang F, Chen H Clin Exp Med. 2022; 23(2):347-355.

PMID: 35389157 DOI: 10.1007/s10238-022-00825-0.


The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes.

Zheng Y, Ran Y, Zhang H, Wang B, Zhou L Front Physiol. 2021; 12:715852.

PMID: 34690796 PMC: 8531204. DOI: 10.3389/fphys.2021.715852.


References
1.
Longhi M, Meda F, Wang P, Samyn M, Mieli-Vergani G, Vergani D . Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology. 2008; 47(2):581-91. DOI: 10.1002/hep.22071. View

2.
Lleo A, Selmi C, Invernizzi P, Podda M, Coppel R, Mackay I . Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. 2009; 49(3):871-9. PMC: 2665925. DOI: 10.1002/hep.22736. View

3.
Irie J, Wu Y, Wicker L, Rainbow D, Nalesnik M, Hirsch R . NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med. 2006; 203(5):1209-19. PMC: 2121204. DOI: 10.1084/jem.20051911. View

4.
Long S, Quan C, Van de Water J, Nantz M, Kurth M, BARSKY D . Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol. 2001; 167(5):2956-63. DOI: 10.4049/jimmunol.167.5.2956. View

5.
Oertelt S, Lian Z, Cheng C, Chuang Y, Padgett K, He X . Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol. 2006; 177(3):1655-60. DOI: 10.4049/jimmunol.177.3.1655. View